![Gina M. Wallar](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profile
Gina M.
Wallar worked as a Director at LabCorp Clinical Trials.
She then worked at NeoGenomics, Inc. as the President-Pharma Services Division from 2021 to 2022.
Dr. Wallar holds a doctorate degree from the University of California, Los Angeles.
Former positions of Gina M. Wallar
| Companies | Position | End |
|---|---|---|
| NEOGENOMICS, INC. | Corporate Officer/Principal | 27/05/2022 |
LabCorp Clinical Trials
 LabCorp Clinical Trials Hospital/Nursing ManagementHealth Services Provides healthcare services | Director/Board Member | - |
Training of Gina M. Wallar
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
16
1st degree connections
3
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
NeoGenomics, Inc.
 NeoGenomics, Inc. Medical/Nursing ServicesHealth Services Provides genetic and molecular testing services | Health Services |
University of California, Los Angeles
 University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
LabCorp Clinical Trials
LabCorp Clinical Trials Hospital/Nursing ManagementHealth Services Provides healthcare services | Health Services |
- Stock Market
- Insiders
- Gina M. Wallar
